Tag: Miracor

Miracor Medical Raises 24M€

Funds will be used for clinical studies and initiation of commercialization AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has announced the closing of a 24M€ Series-E round of financing. The round was led by a new corporate strategic investor joined by co-investor Yonghua. Current investors Earlybird, Noshaq, Quest for Growth, […]

Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System

AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients. The FDA Breakthrough Device designation is intended to speed time to market for treatments of life-threatening or irreversibly debilitating diseases […]

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients. The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, […]

Miracor Medical closes final tranche of Series-D, bringing the round to €30M

AWANS, Belgium, Sept. 4, 2018 /PRNewswire/ — Miracor Medical SA (Miracor Medical) today announced the final closing of the Series D financing round of €30M. The Series D capital will be used to further develop and commercialize the PiCSO® Impulse System. The Series-D round was led by Ming Capital (Shenzhen, China) and co-led by a […]

Miracor Medical Raises €25M

AWANS, Belgium & VIENNA–(BUSINESS WIRE)– Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) today announced the closing of € 25m as part of a Series D financing round. The new capital will be used to further develop and commercialize the PiCSO®Impulse System. The round was led by Ming Capital (Shenzhen, China) […]